Microfluidic Antiperspirant Efficacy Evaluation System

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for evaluating the efficacy of antiperspirant products, particularly those without high aluminum salt content, are inefficient and unable to reliably predict in vivo performance, as existing in vitro and in vivo tests are time-consuming and lack accuracy in assessing the antiperspirant potential of new products.

Innovation Solution

A microfluidic evaluation system comprising a natural or artificial sweat source and a microfluidic chip with a main flow channel for the antiperspirant product and secondary channels for sweat, where physical-chemical parameters such as clog formation can be measured to assess the antiperspirant efficacy, utilizing a measuring unit with pressure sensors and imaging tools to determine the effectiveness of the product.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If in vivo gravimetric tests are used to evaluate antiperspirant efficacy, then measurement accuracy is improved, but testing time and complexity increase significantly

Engineering Contradiction:
Improveefficacy measurement accuracyVSAvoidtesting time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention creates a microfluidic copy of the human sweat gland structure and function. The device replicates the biological system's key characteristics - sweat production, secretion through ducts, and interaction with antiperspirant agents - allowing in vitro evaluation that accurately predicts in vivo performance without requiring time-consuming human subject tests

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The invention replaces the mechanical/gravimetric measurement system used in in vivo tests with an optical detection system. By using imaging tools and light-based methods to detect clog formation and sweat flow reduction in the microfluidic channels, the system achieves comparable measurement accuracy without the time constraints of human subject testing

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Productivity

If existing in vitro methods based on protein flocculation or filter clogging are used, then testing speed is improved, but predictive accuracy for in vivo efficacy deteriorates

Engineering Contradiction:
Improvetesting speedVSAvoidin vivo efficacy prediction accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The invention applies local quality by creating secondary channels with specific dimensional characteristics (diameter less than 100 μm) that replicate the microenvironment of human sweat ducts. This localized structural fidelity in the critical interaction zone between antiperspirant and sweat ensures that the simplified in vitro model accurately predicts in vivo performance while maintaining rapid testing capability

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention changes the key parameter of channel diameter to less than 100 μm, which is critical for reproducing the physical conditions of sweat ducts. This parameter change enables the system to capture the relevant physics of antiperspirant action (clog formation, flow restriction) at the appropriate scale, bridging the gap between simplified in vitro models and complex in vivo conditions

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The microfluidic system provides a rapid, reliable, and cost-effective method for evaluating antiperspirant efficacy, mimicking in vivo conditions and allowing for the assessment of multiple products, thereby overcoming the limitations of existing testing methods.

Implementation Method 1

Certain approaches, carried out in vitro, are based on the capacity that certain antiperspirant agents such as aluminum salts have in inducing the flocculation of proteins in an aqueous pH-neutral solution

Methodology Applied
Scientific EffectFlocculation: Flocculation

Implementation Method 2

The precipitation of mucine by aluminium

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Data Source

PatentUS9943844B2Microfluidic evaluation system for evaluating the efficacy of an antiperspirant product and associated method
Publication Date: 2018.04.17 LOREAL SA
  • US9943844B2 patent drawing
  • US9943844B2 patent drawing
  • US9943844B2 patent drawing

AI summary

This applicator comprises a base (22) and a product applicator tongue (25) that projects from the base (22) along an axis (A-A′), said tongue (25) defining a central cavity (30). It comprises a massage element (32) disposed in the central cavity (30), with the massage (32) element and the tongue (25) defining therebetween in the cavity (30) an intermediary product retaining space (33). The massage element (32) and the tongue (25) can move in relation to one another transversally in relation to the axis (A-A′).